Download Longevity & Mortality Investor Volume 2, Issue 5, May 2026
New data published by life settlement provider, Coventry, suggests that the secondary life settlement market returned to growth in 2025 after a pull-back the year before. Greg Winterton spoke to Rob Haynie, Managing Director at Life Insurance Settlements, Neal Jacobs, Senior Managing Director, Capital Markets at Coventry and Adam Meltzer, Managing Partner of Apex Capital Partners to get their thoughts on the news in Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains.
The Bank of England’s regulator has proposed a change in the capital treatment of life insurers’ use of funded reinsurance, a capital management strategy that helps offset longevity and investment exposures acquired in bulk purchase annuity deals. Mark McCord spoke with Michael Abramson, Partner and Risk Transfer Specialist at Hymans Robertson, to get his initial thoughts on the proposal in Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market.
The proprietary reverse mortgage market in the US – the non-agency-backed part of the space – overtook the agency-backed space in aggregate origination values for the first time in Q1 this year. Greg Winterton spoke to Michael McCully, Partner at New View Advisors, to get his thoughts on how this development impacts institutional capital pools in Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors.
The UK’s pension risk transfer market is as busy as ever in terms of activity, but it could be even higher if it were not for human capital constraints. Mark McCord spoke to Dean Wetton, Founder and Managing Director of Dean Wetton Advisory and Chris Parrott, Professional Trustee at BESTrustees to learn more about the challenges in As PRT Market Grows, Service Providers Look for Ways to Keep Up.
The PHL Variable Life Insurance Co saga is, two years on, approaching its conclusion, and there are both micro and macro impacts for the life settlement market. Greg Winterton spoke to Brian Casey, Partner at Troutman Pepper Locke, and Chris Conway, Managing Director at Vitaro Group, to get their views on the latter in Two Years On, PHL Variable Saga Approaches Conclusion.
The distinction between early and late diagnosis of chronic diseases extends beyond clinical medicine into the domains of insurance and life settlements, where life expectancy serves as a critical input for decision-making. Dr. Jyotsna Kamble, Medical Underwriter at CG Analysts, discusses how certain diseases develop and the impact on longevity risk in Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications, a guest article.
No longer a back-office function, pensions administration has become a pivotal strategic driver for UK schemes eyeing the endgame. Greg Winterton spoke to Daniel Taylor, Client Director at Trafalgar House, to explore the essential priorities for trustees navigating the complex path toward de-risking in this month’s Q&A.
Third-party capital in the asset intensive life reinsurance market now sits at all-time highs, but just how much higher can it go? Greg Winterton spoke to Richard De Haan, Global Risk Modelling Services Leader at PwC in New York, to get his thoughts on the market generally and its potential in Will US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?
I hope you enjoy the latest issue of Longevity and Mortality Investor.
Chris Wells
Managing Editor
Longevity and Mortality Investor
